These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1100 related articles for article (PubMed ID: 8894649)

  • 61. Insulin-like growth factor binding proteins (IGFBPs) in acromegaly.
    Coulson VJ; Wass JA; Abdulla AF; Cotterill AM; Holly JM
    Growth Regul; 1991 Sep; 1(3):119-24. PubMed ID: 1726836
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Protease-induced alteration of insulin-like growth factor binding protein-3 as detected by radioimmunoassay. Agreement with ligand blotting data.
    Lassarre C; Lalou C; Perin L; Binoux M
    Growth Regul; 1994 Jun; 4(2):48-55. PubMed ID: 7524885
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Different states of clinical control are associated with changes in IGF-I and IGFBPs in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Cunha HM; Elias LL; Camacho-Hübner C; Moreira AC; Martinelli CE
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):94-101. PubMed ID: 15212650
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Plasma levels of insulin-like binding protein-2 in prepubertal short children and its diagnostic value in the evaluation of growth hormone deficiency.
    van Doorn J; Ringeling AM; Rikken B; van Buul-Offers SC
    Horm Res; 2001; 55(3):147-54. PubMed ID: 11549877
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery.
    Cotterill AM; Mendel P; Holly JM; Timmins AG; Camacho-Hübner C; Hughes SC; Ross RM; Blum WF; Langford RM
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):91-101. PubMed ID: 8706300
    [TBL] [Abstract][Full Text] [Related]  

  • 66. IGFs and binding proteins in short children with intrauterine growth retardation.
    Cutfield WS; Hofman PL; Vickers M; Breier B; Blum WF; Robinson EM
    J Clin Endocrinol Metab; 2002 Jan; 87(1):235-9. PubMed ID: 11788652
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Insulin-like growth factor binding proteins in prepubertal children with insulin-dependent diabetes mellitus.
    Knip M; Tapanainen P; Pekonen F; Blum WF
    Eur J Endocrinol; 1995 Oct; 133(4):440-4. PubMed ID: 7581967
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Decreased ternary complex formation and predominance of a 29 kDa IGFBP-3 fragment in human fetal serum.
    Bang P; Stangenberg M; Westgren M; Rosenfeld RG
    Growth Regul; 1994 Jun; 4(2):68-76. PubMed ID: 7524886
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bioactivity of a 29-kilodalton insulin-like growth factor binding protein-3 fragment present in excess in chronic renal failure serum.
    Durham SK; Mohan S; Liu F; Baker BK; Lee PD; Hintz RL; Conover CA; Powell DR
    Pediatr Res; 1997 Sep; 42(3):335-41. PubMed ID: 9284274
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Characterization of a low molecular mass form of insulin-like growth factor binding protein-3 (17.7 kilodaltons) in urine and serum from healthy children and growth hormone (GH)-deficient patients: relationship with GH therapy.
    Spagnoli A; Gargosky SE; Spadoni GL; MacGillivray M; Oh Y; Boscherini B; Rosenfeld RG
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3668-76. PubMed ID: 8530618
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A low-molecular-weight (25-kDa) IGF-binding protein is increased with growth inhibition in the fasting striped bass, Morone saxatilis.
    Siharath K; Kelley KM; Bern HA
    Gen Comp Endocrinol; 1996 Jun; 102(3):307-16. PubMed ID: 8804561
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The insulin-like growth factor axis and growth in children with chronic renal failure: a report of the Southwest Pediatric Nephrology Study Group.
    Powell DR; Durham SK; Liu F; Baker BK; Lee PD; Watkins SL; Campbell PG; Brewer ED; Hintz RL; Hogg RJ
    J Clin Endocrinol Metab; 1998 May; 83(5):1654-61. PubMed ID: 9589673
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
    Frystyk J; Ivarsen P; Skjaerbaek C; Flyvbjerg A; Pedersen EB; Orskov H
    Kidney Int; 1999 Dec; 56(6):2076-84. PubMed ID: 10594783
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease.
    Krassas GE; Pontikides N; Kaltsas T; Dumas A; Frystyk J; Chen JW; Flyvbjerg A
    J Clin Endocrinol Metab; 2003 Jan; 88(1):132-5. PubMed ID: 12519841
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
    Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Insulin-like growth factor (IGF)-I and -II and IGF-binding proteins-1, -2, and -3 in children and adolescents with diabetes mellitus: correlation with metabolic control and height attainment.
    Strasser-Vogel B; Blum WF; Past R; Kessler U; Hoeflich A; Meiler B; Kiess W
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1207-13. PubMed ID: 7536202
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Residual β-cell function and the insulin-like growth factor system in Danish children and adolescents with type 1 diabetes.
    Sorensen JS; Birkebaek NH; Bjerre M; Pociot F; Kristensen K; Hoejberg AS; Frystyk J;
    J Clin Endocrinol Metab; 2015 Mar; 100(3):1053-61. PubMed ID: 25532040
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
    Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish pediatric population: age- and sex-related changes.
    Argente J; Barrios V; Pozo J; Muñoz MT; Hervás F; Stene M; Hernández M
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1522-8. PubMed ID: 7505288
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
    Benbassat CA; Maki KC; Unterman TG
    J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.